Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23267856 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Anti-MAG First Administration to Human
Conditions: Chronic Diseases Associated With Axonal Damage;   Cerebrovascular Accident
Interventions: Drug: GSK249320;   Drug: Placebo

Indicates status has not been verified in more than two years